CLINICAL_TRIALS
trial_result
· 2020-04-20
Clinical Trial Update: A Study Examining the Medication Apremilast as Treatment for Chronic Itch [Phase 2]
Summary
Phase 2 trial evaluating apremilast for chronic itch has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Itch | Phase 2 | Status: COMPLETED | Results posted: 2020-04-20